MCBR has a provision to facilitate Biopharma companies with GMP lab/infra-structure to start MAHE-Pvt. Partnership research unit at MAHE at a very nominal usage fee or potential option to outsource translational research projects to MCBR.

MCBR is at Advanced stage of collaborative discussions with

??????? Stempeutics 365体育投注--官网直营网站@

??????? Curio Biotech, Switzerland

??????? Esco Aster, Singapore

??????? Cipla Ltd

We welcome more collaborative initiative to the companies for developing novel Biotherapeutics products.